BRISTOL-MYERS SQUIBB CO (BMY)
US1101221083 - Common Stock
Want Decades of Passive Income? 3 Stocks to Buy Right Now
Passive income requires solid companies and a solid underlying industry. Here are some top names that fit both bills.
Bristol Myers Squibb Stock Earns 83 RS Rating
On Thursday, Bristol Myers Squibb stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.
3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income
Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
Got $250? 2 Healthcare Stocks to Buy and Hold Forever
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program
/PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that it has entered into a global exclusive license agreement with Bristol Myers...
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:PFE),(NYSE:GSK),(NYSE:BMY) EQNX::TICKER_END
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Pfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Tuesday Sector Leaders: Healthcare, Consumer Products
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
Which S&P500 stocks are moving on Tuesday?
Netflix, MongoDB downgraded: Wall Street's top analyst calls
Netflix, MongoDB downgraded: Wall Street's top analyst calls
Bristol Myers Squibb Announces Dividend Increase
Is Bristol-Myers Squibb Stock a Millionaire Maker?
3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever
The sell-offs of these stocks were driven by issues that were never going to last.
AstraZeneca’s Enhertu Wins China Reimbursement Despite Probe
China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance, a move that will boost the British drugmaker’s sales in the country in the midst of an ongoing probe that’s ensnared some of its senior executives.
Bristol Myers Squibb to Participate in Citi’s 2024 Global Healthcare Conference
Where Will Bristol Myers Squibb Be in 5 Years?
AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
AbbVie's schizophrenia treatment, courtesy of its Cerevel takeover, missed the market in two studies. But an analyst says there's still more to like.
Is Bristol Myers Squibb Stock a Buy?
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
